These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19011053)

  • 1. Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors.
    Yoneyama F; Imura Y; Ichimasa S; Fujita K; Zendo T; Nakayama J; Matsuzaki K; Sonomoto K
    Appl Environ Microbiol; 2009 Jan; 75(2):538-41. PubMed ID: 19011053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactococcal membrane-permeabilizing antimicrobial peptides.
    Zendo T; Yoneyama F; Sonomoto K
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):1-9. PubMed ID: 20645082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal hydroxyl radical accumulation by a lactococcal bacteriocin, lacticin Q.
    Li M; Yoneyama F; Toshimitsu N; Zendo T; Nakayama J; Sonomoto K
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3897-902. PubMed ID: 23733459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria.
    Fujita K; Ichimasa S; Zendo T; Koga S; Yoneyama F; Nakayama J; Sonomoto K
    Appl Environ Microbiol; 2007 May; 73(9):2871-7. PubMed ID: 17351096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the genes involved in the secretion and self-immunity of lacticin Q, an unmodified leaderless bacteriocin from Lactococcus lactis QU 5.
    Iwatani S; Yoneyama F; Miyashita S; Zendo T; Nakayama J; Sonomoto K
    Microbiology (Reading); 2012 Dec; 158(Pt 12):2927-2935. PubMed ID: 23103973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacticin Q-mediated selective toxicity depending on physicochemical features of membrane components.
    Yoneyama F; Ohno K; Imura Y; Li M; Zendo T; Nakayama J; Matsuzaki K; Sonomoto K
    Antimicrob Agents Chemother; 2011 May; 55(5):2446-50. PubMed ID: 21282423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic action of pediocin and nisin: recent progress and unresolved questions.
    Montville TJ; Chen Y
    Appl Microbiol Biotechnol; 1998 Nov; 50(5):511-9. PubMed ID: 9917136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactococcal bacteriocins: mode of action and immunity.
    Venema K; Venema G; Kok J
    Trends Microbiol; 1995 Aug; 3(8):299-304. PubMed ID: 8528613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nisin Z and lacticin 3147 improve efficacy of antibiotics against clinically significant bacteria.
    Ellis JC; Ross RP; Hill C
    Future Microbiol; 2019 Dec; 14():1573-1587. PubMed ID: 32019322
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening and characterization of novel bacteriocins from lactic acid bacteria.
    Zendo T
    Biosci Biotechnol Biochem; 2013; 77(5):893-9. PubMed ID: 23649268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
    Morgan SM; O'connor PM; Cotter PD; Ross RP; Hill C
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2606-11. PubMed ID: 15980326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5.
    Paiva AD; Breukink E; Mantovani HC
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5284-93. PubMed ID: 21876041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action and structure-activity relationship studies of geobacillin I.
    Garg N; Oman TJ; Andrew Wang TS; De Gonzalo CV; Walker S; van der Donk WA
    J Antibiot (Tokyo); 2014 Jan; 67(1):133-6. PubMed ID: 24169799
    [No Abstract]   [Full Text] [Related]  

  • 14. Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q.
    Yoneyama F; Imura Y; Ohno K; Zendo T; Nakayama J; Matsuzaki K; Sonomoto K
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3211-7. PubMed ID: 19470516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo cluster formation of nisin and lipid II is correlated with membrane depolarization.
    Tol MB; Morales Angeles D; Scheffers DJ
    Antimicrob Agents Chemother; 2015; 59(6):3683-6. PubMed ID: 25870072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Lactococcus-Specific Bacteriocins Produced by Lactococcal Isolates, and the Discovery of a Novel Bacteriocin, Lactococcin Z.
    Ishibashi N; Seto H; Koga S; Zendo T; Sonomoto K
    Probiotics Antimicrob Proteins; 2015 Sep; 7(3):222-31. PubMed ID: 26093857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Magnetic Resonance Solution Structures of Lacticin Q and Aureocin A53 Reveal a Structural Motif Conserved among Leaderless Bacteriocins with Broad-Spectrum Activity.
    Acedo JZ; van Belkum MJ; Lohans CT; Towle KM; Miskolzie M; Vederas JC
    Biochemistry; 2016 Feb; 55(4):733-42. PubMed ID: 26771761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens.
    Ryan MP; Meaney WJ; Ross RP; Hill C
    Appl Environ Microbiol; 1998 Jun; 64(6):2287-90. PubMed ID: 9603853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory expression of lacticin Q fused with SUMO in Bacillus subtilis.
    Yu Z; Wang Q; Ma Q; Zhang R
    Protein Expr Purif; 2013 May; 89(1):51-5. PubMed ID: 23473826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity. A monolayer study.
    Demel RA; Peelen T; Siezen RJ; De Kruijff B; Kuipers OP
    Eur J Biochem; 1996 Jan; 235(1-2):267-74. PubMed ID: 8631341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.